Erratum: DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias (Cancer Cell (2016) 29(6) (922–934) (S1535610816302082) (10.1016/j.ccell.2016.05.003));DNMT3A Loss Drives Enhancer Hypomethylation in FLT3-ITD-Associated Leukemias

Cancer Cell

Volumn 29, Issue 6, 2016, Pages 922-934

  Yang, Liubin ^a   Rodriguez, Benjamin ^a   Mayle, Allison ^a   Park, Hyun Jung ^a   Lin, Xueqiu ^a,b   Luo, Min ^a   Jeong, Mira ^a   Curry, Choladda V ^a   Kim, Sang Bae ^c   Ruau, David ^e   Zhang, Xiaotian ^a   Zhou, Ting ^f   Zhou, Michael ^g   Rebel, Vivienne I ^f   Challen, Grant A ^d   Göttgens, Berthold ^e   Lee, Ju Seog ^c   Rau, Rachel ^a   Li, Wei ^a   Goodell, Margaret A ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TONGJI UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^f Mays Cancer Center at UT Health San Antonio   (United States)

^g RICE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD135 ANTIGEN; DNA; DNA METHYLTRANSFERASE 3A; DNA (CYTOSINE 5) METHYLTRANSFERASE; FLT3 PROTEIN, HUMAN;

ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; ENHANCER REGION; GENE DUPLICATION; GENE MUTATION; GENE ONTOLOGY; HEMATOPOIETIC STEM CELL; HETEROZYGOTE; HUMAN; INTERNAL TANDEM DUPLICATION; LEUKEMIA; LYMPHATIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETIC EPIGENESIS; GENETICS; MUTATION;

ANIMALS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; FMS-LIKE TYROSINE KINASE 3; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HUMANS; LEUKEMIA; MICE; MUTATION; NEOPLASMS, EXPERIMENTAL;

EID: 84979528611     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.07.015     Document Type: Erratum

References (45)

1. Boyle, P., Clement, K., Gu, H., Smith, Z.D., Ziller, M., Fostel, J.L., Holmes, L., Meldrim, J., Kelley, F., Gnirke, A., et al. Gel-free multiplexed reduced representation bisulfite sequencing for large-scale DNA methylation profiling. Genome Biol., 13, 2012, R92.
2. Cancer Genome Atlas Research Network, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368 (2013), 2059–2074.
3. Celik, H., Mallaney, C., Kothari, A., Ostrander, E.L., Eultgen, E., Martens, A., Miller, C.A., Hundal, J., Klco, J.M., Challen, G.A., Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation. Blood 125 (2015), 619–628.
4. Challen, G.A., Sun, D., Jeong, M., Luo, M., Jelinek, J., Berg, J.S., Bock, C., Vasanthakumar, A., Gu, H., Xi, Y., et al. Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44 (2012), 23–31.
5. Cleveland, S.M., Goodings, C., Tripathi, R.M., Elliott, N., Thompson, M.A., Guo, Y., Shyr, Y., Davé, U.P., LMO2 induces T-cell leukemia with epigenetic deregulation of CD4. Exp. Hematol. 42 (2014), 581–593.e5.
6. Corces-Zimmerman, M.R., Hong, W.J., Weissman, I.L., Medeiros, B.C., Majeti, R., Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission. Proc. Natl. Acad. Sci. USA 111 (2014), 2548–2553.
7. Coustan-Smith, E., Mullighan, C.G., Onciu, M., Behm, F.G., Raimondi, S.C., Pei, D., Cheng, C., Su, X., Rubnitz, J.E., Basso, G., et al. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia. Lancet Oncol. 10 (2009), 147–156.
8. Ding, L., Ley, T.J., Larson, D.E., Miller, C.A., Koboldt, D.C., Welch, J.S., Ritchey, J.K., Young, M.A., Lamprecht, T., McLellan, M.D., et al. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature 481 (2012), 506–510.
9. Gerloff, D., Grundler, R., Wurm, A.A., Bräuer-Hartmann, D., Katzerke, C., Hartmann, J.-U., Madan, V., Muller-Tidow, C., Duyster, J., Tenen, D.G., et al. NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia. Leukemia 29 (2015), 535–547.
10. Grossmann, V., Haferlach, C., Weissmann, S., Roller, A., Schindela, S., Poetzinger, F., Stadler, K., Bellos, F., Kern, W., Haferlach, T., et al. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL. Genes Chromosomes Cancer 52 (2013), 410–422.
11. Haferlach, T., Kohlmann, A., Wieczorek, L., Basso, G., Kronnie, G.T., Bene, M.C., De Vos, J., Hernandez, J.M., Hofmann, W.K., Mills, K.I., et al. Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group. J. Clin. Oncol. 28 (2010), 2529–2537.
12. Hinkal, G., Parikh, N., Donehower, L.A., Timed somatic deletion of p53 in mice reveals age-associated differences in tumor progression. PLoS One, 4, 2009, e6654.
13. Hon, G.C., Rajagopal, N., Shen, Y., McCleary, D.F., Yue, F., Dang, M.D., Ren, B., Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat. Genet. 45 (2013), 1198–1206.
14. Jan, M., Snyder, T.M., Corces-Zimmerman, M.R., Vyas, P., Weissman, I.L., Quake, S.R., Majeti, R., Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia. Sci. Transl. Med., 4, 2012, 149ra118.
15. Jeong, M., Sun, D., Luo, M., Huang, Y., Challen, G.A., Rodriguez, B., Zhang, X., Chavez, L., Wang, H., Hannah, R., et al. Large conserved domains of low DNA methylation maintained by Dnmt3a. Nat. Genet. 46 (2014), 17–23.
16. Kelly, L.M., Kutok, J.L., Williams, I.R., Boulton, C.L., Amaral, S.M., Curley, D.P., Ley, T.J., Gilliland, D.G., PML/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model. Proc. Natl. Acad. Sci. USA 99 (2002), 8283–8288.
17. Kim, S.J., Zhao, H., Hardikar, S., Singh, A.K., Goodell, M.A., Chen, T., A DNMT3A mutation common in AML exhibits dominant-negative effects in murine ES cells. Blood 122 (2013), 4086–4089.
18. Kogan, S.C., Bethesda proposals for classification of nonlymphoid hematopoietic neoplasms in mice. Blood 100 (2002), 238–245.
19. Krivtsov, A.V., Twomey, D., Feng, Z., Stubbs, M.C., Wang, Y., Faber, J., Levine, J.E., Wang, J., Hahn, W.C., Gilliland, D.G., et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9. Nature 442 (2006), 818–822.
20. Lara-Astiaso, D., Weiner, A., Lorenzo-Vivas, E., Zaretsky, I., Jaitin, D.A., David, E., Keren-Shaul, H., Mildner, A., Winter, D., Jung, S., et al. Immunogenetics. Chromatin state dynamics during blood formation. Science 345 (2014), 943–949.
21. Lee, B.H., Tothova, Z., Levine, R.L., Anderson, K., Buza-Vidas, N., Cullen, D.E., McDowell, E.P., Adelsperger, J., Frohling, S., Huntly, B.J., et al. FLT3 mutations confer enhanced proliferation and survival properties to multipotent progenitors in a murine model of chronic myelomonocytic leukemia. Cancer Cell 12 (2007), 367–380.
22. Ley, T.J., Ding, L., Walter, M.J., McLellan, M.D., Lamprecht, T., Larson, D.E., Kandoth, C., Payton, J.E., Baty, J., Welch, J., et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 363 (2010), 2424–2433.
23. Mayle, A., Luo, M., Jeong, M., Goodell, M.A., Flow cytometry analysis of murine hematopoietic stem cells. Cytometry A 83 (2013), 27–37.
24. Mayle, A., Yang, L., Rodriguez, B., Zhou, T., Chang, E., Curry, C.V., Challen, G.A., Li, W., Wheeler, D., Rebel, V.I., et al. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation. Blood 125 (2015), 629–638.
25. Mok, M.M.H., Du, L., Wang, C.Q., Tergaonkar, V., Liu, T.C., Kham, S.K.Y., Sanda, T., Yeoh, A.E.-J., Osato, M., RUNX1 point mutations potentially identify a subset of early immature T-cell acute lymphoblastic leukaemia that may originate from differentiated T-cells. Gene 545 (2014), 111–116.
26. Morse, H.C. 3rd, Anver, M.R., Fredrickson, T.N., Haines, D.C., Harris, A.W., Harris, N.L., Jaffe, E.S., Kogan, S.C., MacLennan, I.C., Pattengale, P.K., et al. Bethesda proposals for classification of lymphoid neoplasms in mice. Blood 100 (2002), 246–258.
27. Mouse ENCODE Consortium, Stamatoyannopoulos, J., Snyder, M., Hardison, R., Ren, B., Gingeras, T., Gilbert, D., Groudine, M., Bender, M., Kaul, R., et al. An encyclopedia of mouse DNA elements (Mouse ENCODE). Genome Biol., 13, 2012, 418.
28. Neumann, M., Heesch, S., kbuget, N.G.O., Schwartz, S., Schlee, C., Benlasfer, O., Farhadi-Sartangi, N., Thibaut, J., Burmeister, T., Hoelzer, D., et al. Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations. Blood Cancer J. 2 (2012), e55–57.
29. Neumann, M., Heesch, S., Schlee, C., Schwartz, S., Gokbuget, N., Hoelzer, D., Konstandin, N.P., Ksienzyk, B., Vosberg, S., Graf, A., et al. Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations. Blood 121 (2013), 4749–4752.
30. Qu, Y., Lennartsson, A., Gaidzik, V.I., Deneberg, S., Karimi, M., Bengtzen, S., Hoglund, M., Bullinger, L., Dohner, K., Lehmann, S., Differential methylation in CN-AML preferentially targets non-CGI regions and is dictated by DNMT3A mutational status and associated with predominant hypomethylation of HOX genes. Epigenetics 9 (2014), 1108–1119.
31. Rathinam, C., Thien, C.B.F., Flavell, R.A., Langdon, W.Y., Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling. Cancer Cell 18 (2010), 341–352.
32. Ruau, D., Ng, F.S., Wilson, N.K., Hannah, R., Diamanti, E., Lombard, P., Woodhouse, S., Gottgens, B., Building an ENCODE-style data compendium on a shoestring. Nat. Methods, 10, 2013, 926.
33. Russler-Germain, D.A., Spencer, D.H., Young, M.A., Lamprecht, T.L., Miller, C.A., Fulton, R., Meyer, M.R., Erdmann-Gilmore, P., Townsend, R.R., Wilson, R.K., et al. The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers. Cancer Cell 25 (2014), 442–454.
34. Shen, Y., Yue, F., McCleary, D.F., Ye, Z., Edsall, L., Kuan, S., Wagner, U., Dixon, J., Lee, L., Lobanenkov, V.V., et al. A map of the cis-regulatory sequences in the mouse genome. Nature 488 (2013), 116–120.
35. Shlush, L.I., Zandi, S., Mitchell, A., Chen, W.C., Brandwein, J.M., Gupta, V., Kennedy, J.A., Schimmer, A.D., Schuh, A.C., Yee, K.W., et al. Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia. Nature 506 (2014), 328–333.
36. Smeets, M.F.M.A., Chan, A.C., Dagger, S., Bradley, C.K., Wei, A., Izon, D.J., Fli-1 overexpression in hematopoietic progenitors deregulates T cell development and induces pre-t cell lymphoblastic leukaemia/lymphoma. PLoS One, 8, 2013, e62346.
37. Smeets, M.F.M.A., Wiest, D.L., Izon, D.J., Fli-1 regulates the DN2 to DN3 thymocyte transition and promotes γδ T-cell commitment by enhancing TCR signal strength. Eur. J. Immunol. 44 (2014), 2617–2624.
38. Smith, S., Tripathi, R., Goodings, C., Cleveland, S., Mathias, E., Hardaway, J.A., Elliott, N., Yi, Y., Chen, X., Downing, J., et al. Lim domain Only-2 (LMO2) induces t-cell leukemia by two distinct pathways. PLoS One, 9, 2014, e85883.
39. Van Vlierberghe, P., Ambesi-Impiombato, A., Perez-Garcia, A., Haydu, J.E., Rigo, I., Hadler, M., Tosello, V., Della Gatta, G., Paietta, E., Racevskis, J., et al. ETV6 mutations in early immature human T cell leukemias. J. Exp. Med. 208 (2011), 2571–2579.
40. Van Vlierberghe, P., Ambesi-Impiombato, A., De Keersmaecker, K., Hadler, M., Paietta, E., Tallman, M.S., Rowe, J.M., Forne, C., Rue, M., Ferrando, A.A., Prognostic relevance of integrated genetic profiling in adult T-cell acute lymphoblastic leukemia. Blood 122 (2013), 74–82.
41. Xie, M., Lu, C., Wang, J., McLellan, M.D., Johnson, K.J., Wendl, M.C., McMichael, J.F., Schmidt, H.K., Yellapantula, V., Miller, C.A., et al. Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20 (2014), 1472–1478.
42. Yan, X.J., Xu, J., Gu, Z.H., Pan, C.M., Lu, G., Shen, Y., Shi, J.Y., Zhu, Y.M., Tang, L., Zhang, X.W., et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat. Genet. 43 (2011), 309–315.
43. Yang, L., Rau, R., Goodell, M.A., DNMT3A in haematological malignancies. Nat. Rev. Cancer 15 (2015), 152–165.
44. You, J.S., Jones, P.A., Cancer genetics and epigenetics: two sides of the same coin?. Cancer Cell 22 (2012), 9–20.
45. Zhang, Y., Liu, T., Meyer, C.A., Eeckhoute, J., Johnson, D.S., Bernstein, B.E., Nusbaum, C., Myers, R.M., Brown, M., Li, W., et al. Model-based analysis of ChIP-seq (MACS). Genome Biol., 9, 2008, R137.